Multiplex plasma protein profiling identifies novel markers to discriminate patients with adenocarcinoma of the lung

BACKGROUND: The overall prognosis of non-small cell lung cancer (NSCLC) is poor, and currently only patients with localized disease are potentially curable. Therefore, preferably non-invasively determined biomarkers that detect NSCLC patients at early stages of the disease are of high clinical relev...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Cancer
Päätekijät: Djureinovic, Dijana, Pontén, Victor, Landelius, Per, Al Sayegh, Sahar, Kappert, Kai, Kamali-Moghaddam, Masood, Micke, Patrick, Ståhle, Elisabeth
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2019
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6664554/
https://ncbi.nlm.nih.gov/pubmed/31357969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-5943-3
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia